Is major pathologic response sufficient to predict survival in resectable nonsmall‐cell lung cancer patients receiving neoadjuvant chemotherapy?-Reference-Cited by-同舟云学术

Is major pathologic response sufficient to predict survival in resectable nonsmall‐cell lung cancer patients receiving neoadjuvant chemotherapy?

Published:2021-03-10 Issue:9 Volume:12 Page:1336-1346
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Cai Jing‐Sheng¹²^ORCID,Li Shuo¹²,Yan Shu‐Mei²³,Yang Jie¹²^ORCID,Yang Mu‐Zi¹²^ORCID,Xie Chu‐Long¹²^ORCID,Li Ji‐Bin²⁴,Feng Yan‐Fen²³,Yang Hao‐Xian¹²,Hou Xue²⁵

Affiliation:

1. Department of Thoracic Surgery Sun Yat‐sen University Cancer Center Guangzhou China

2. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou China

3. Department of Pathology Sun Yat‐sen University Cancer Center Guangzhou China

4. Department of Epidemiology and Biostatistic Sun Yat‐sen University Cancer Center Guangzhou China

5. Department of Medical Oncology Sun Yat‐sen University Cancer Center Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13903

Reference31 articles.